Maynard Um
-
-
-
-
-
-
-
TD Cowen notes short interest shifts in life science tools stocks
-
-
-
-
-
-
-
10X Genomics (TXG) PT Raised to $25 at Stifel on Solid New Product Adoption
-
-
-
-
-
-
-
10X Genomics (TXG) PT Raised to $21 at BofA Securities
-
-
-
-
-
-
-
Piper Sandler Starts 10X Genomics (TXG) at Neutral
-
-
-
-
-
-
-
10x Genomics (TXG) Tops Q1 EPS by 19c, provides guidance
-
-
-
-
-
-
-
U.S. District Court Awards 10x Genomics (TXG) Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
-
-
-
-
-
-
-
BofA Securities Reiterates Neutral Rating on 10X Genomics (TXG)
-
443,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

